Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Dalfampridine: A Medication to Improve Walking in Patients with Multiple Sclerosis (July/August).
Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling.
Hypomethylating Agent 5-Aza-2'-deoxycytidine (DAC) Ameliorates Multiple Sclerosis in Mouse Models.
Protective Effect of a cAMP Analogue on Behavioral Deficits and Neuropathological Changes in Cuprizone Model of Demyelination.
The Incidence, Prevalence, Costs and Impact on Disability of Common Conditions Requiring Rehabilitation in the US: Stroke, Spinal Cord Injury, Traumatic Brain Injury, Multiple Sclerosis, Osteoarthritis, Rheumatoid Arthritis, Limb Loss, and Back Pain.
A 10-year follow-up of a population-based study of people with multiple sclerosis in Stockholm, Sweden: Changes in health-related quality of life and the value of different factors in predicting health-related quality of life.
An empowerment model of workplace support following disclosure, for people with MS.
Assessment of postural stabilization in three task oriented movements in people with multiple sclerosis.
Improving the quality of mental health care in Multiple Sclerosis.
Low vitamin D level is associated with higher relapse rate in natalizumab treated MS patients.
SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease.
Predicting short-term conversion from CIS to MS: Relevance of lesion distribution.
On the contribution of Thomas Clifford Allbutt, F.R.S., to the early history of neuromyelitis optica.
Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS).
Pathogenesis of multiple sclerosis: what can we learn from the cuprizone model.
No additional copies of HERV-Fc1 in the germ line of multiple sclerosis patients.
Time-Domain and Spectral-Domain Optical Coherence Tomography of Retinal Nerve Fiber Layer in MS Patients and Healthy Controls.
Current and emerging therapies in multiple sclerosis: a systematic review.
Epileptic seizures in Japanese patients with multiple sclerosis and neuromyelitis optica.
Progressive multifocal leukoencephalopathy associated to natalizumab extended dosing regimen.
Novel insights into the development and maintenance of the blood-brain barrier.
Structure-activity relationship study, target identification, and pharmacological characterization of a small molecular IL-12/23 inhibitor, APY0201.
Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients.
Intracellular signaling pathway regulation of myelination and remyelination in the CNS.
Something Old, New, Borrowed, Blue: Anthracenedione Agents for Treatment of Multiple Sclerosis.

Pages